Expanded Safety and Efficacy of Givastomig, a Claudin 18.2/4-1BB Bispecific Antibody, in Combination with Nivolumab and mFOLFOX in 1L Metastatic Gastroesophageal Carcinoma (mGEC)

givastomig (TJ-CD4B) - NovaBridge Biosciences, ABL Bio

Opdivo (nivolumab) - Ono Pharmaceutical, BMS

https://cslide.ctimeetingtech.com/esmo2026/attendee/confcal_1/print/presentation/9252

Samuel J. Klempner; Farshid Dayyani; Jeremy Kratz; Nataliya Uboha; Sunnie Kim; Sangmi Lee; Juyeun Jeon; Chris Ahlers; Claire Xu; Phillip A. Dennis; Geoffrey Ku

Jul 17, 2026